Eton Pharmaceutcials
ETON
56 hedge funds and large institutions have $33.5M invested in Eton Pharmaceutcials in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 9 reducing their positions, and 8 closing their positions.
1,429% more call options, than puts
Call options by funds: $214K | Put options by funds: $14K
111% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 9
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
17% more capital invested
Capital invested by funds: $28.8M → $33.5M (+$4.75M)
12% more funds holding
Funds holding: 50 → 56 (+6)
2.92% more ownership
Funds ownership: 26.9% → 29.81% (+2.9%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Acuitas Investments
Seattle,
Washington
|
+$1.09M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$399K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$205K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$183K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$161K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$1.07M |
| 2 |
Millennium Management
New York
|
-$240K |
| 3 |
Jane Street
New York
|
-$188K |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$126K |
| 5 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$120K |
ETON Hedge Fund Activity: Q4 2023 in Review
56 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q4 2023, worth a combined $33.5M — up 17% from $28.8M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ETON positions and 8 closed out — a net gain of 6 holders — while 19 added to existing stakes and 9 trimmed.
The largest buyer was Acuitas Investments, adding an estimated $1.09M. The largest seller was EAM Investors, exiting entirely with an estimated $1.07M sold.
- 56 institutional investors held Eton Pharmaceutcials (ETON) as of Q4 2023, up from 50 in Q3 2023.
- Funds reported $33.5M of Eton Pharmaceutcials stock for Q4 2023, up 17% quarter-over-quarter.
- 14 funds opened new Eton Pharmaceutcials positions in Q4 2023 and 8 closed out, a net change of +6 holders.
- The largest Eton Pharmaceutcials buyer in Q4 2023 was Acuitas Investments, an estimated $1.09M added.
- The largest Eton Pharmaceutcials seller in Q4 2023 was EAM Investors, an estimated $1.07M sold.
Based on aggregated 13F filings for Q4 2023.